2019 Meet-The-Professor Endocrine Case Management

Meet-The-Professor Case Management is designed to provide physicians with a concise and high-quality review of 55 common and rare endocrine disorders to help you keep your practice current. It consists of case-based clinical cases and rationale by experts in all areas of endocrinology, diabetes, and metabolism.

You must first purchase this through our online store. Once you have completed your purchase you will receive access to this CME activity.

Visit the Online Store to purchase today.

Target Audience

Meet-The-Professor Case Management provides case-based education to clinicians interested in improving patient care.

Learning Objectives

Meet-The-Professor Case Management will allow learners to assess their knowledge of all aspects of endocrinology, diabetes, and metabolism.

Upon completion of this educational activity, learners will be able to:

  • Recognize clinical manifestations of endocrine and metabolic disorders and select among current options for diagnosis, management, and therapy.
  • Identify risk factors for endocrine and metabolic disorders and develop strategies for prevention.
  • Evaluate endocrine and metabolic manifestations of systemic disorders.
  • Use existing resources pertaining to clinical guidelines and treatment recommendations for endocrine and related metabolic disorders to guide diagnosis and treatment.

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Educator/Teacher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Professionalism
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
Quality Improvement and Healthcare Delivery
General Endocrinology
Hormone Abuse
Growth Disorders
Health Disparities
Hormones and Cancer
Men’s Health
Neuroendocrinology and Pituitary
Nutrition
Obesity
Pediatric Endocrinology
Surgery
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 30.00 AMA PRA Category 1 Credits
  • 30.00 CME Certificate of Participation
Course opens: 
03/11/2019
Course expires: 
03/31/2021
Pricing: 
Non-Member
99.00 / e-book $79.00
Member
79.00 / e-book $59.00
In-Training Member
59.00 / e-book $39.00
Rating: 
0

2019 Meet-The-Professor Case Management Faculty

Jasna Aleksova, MBBS, BMedSci
Monash Health Melbourne, Australia

Bradley D. Anawalt, MD
University of Washington

Katherine Araque, MD
National Institutes of Health

Wiebke Arlt, MD, DSc
University of Birmingham, United Kingdom

Richard J. Auchus, MD, PhD
University of Michigan

Ricardo Azziz, MD, MPH, MBA
State University of New York

Linda A. Barbour, MSPH, MD
University of Colorado School of Medicine

Andrew J. Bauer, MD
The Children's Hospital of Philadelphia

Carolyn B. Becker, MD
Brigham and Women's Hospital

Sarah L. Berga, MD
University of Utah School of Medicine

Daniel H. Bessesen, MD
University of Colorado School of Medicine

Petter M. Bjornstad, MD
University of Colorado School of Medicine

Henry B. Burch, MD
National Institutes of Health

Marcelle I. Cedars, MD
University of California, San Francisco

Herbert Chen, MD
University of Alabama, Birmingham

Ellen L. Connor, MD
University of Wisconsin
American Family Children's Hospital

Marc-Andre Cornier, MD
University of Colorado School of Medicine

Wouter W. de Herder, MD, PhD
Erasmus Medical Center, Netherlands

Laura E. Dichtel, MD
Massachusetts General Hospital

William T. Donahoo, MD
University of Florida

Andrea Dunaif, MD
Icahn School of Medicine at Mount Sinai

Peter R. Ebeling, MD
Monash University, Australia

Robert Eckel, MD
University of Colorado Anschutz Medical Campus

Azeez Farooki, MD
Memorial Sloan Kettering Cancer Center

Sergio Fazio, MD, PhD
Oregon Health and Science University

Patricia Y. Fechner, MD
Seattle Children's Hospital

Kenneth Feingold, MD
University of California, San Francisco

James W. Findling, MD
Medical College of Wisconsin

Maria Fleseriu, MD
Oregon Health and Science University

Stephen Franks, MBBS, MD
Imperial College London, United Kingdom

Sheila M. Fraser, MBChB, MD
Leeds Teaching Hospitals NHS Trust, United Kingdom

Andrea Giustina, MD
San Raffaele Vita-Salute University, Italy

Jacqueline N. Gutmann, MD
RMA of Philadelphia
Thomas Jefferson University

Bryan Haugen, MD
University of Colorado School of Medicine

Camilo Jimenez, MD
University of Texas MD Anderson Cancer Center

Jacqueline Jonklaas, MD, PhD
Georgetown University Medical Center

Jens O. Jorgensen, MD, PhD
Aarhus University Hospital, Denmark

Laurence Katznelson, MD
Stanford University
 

Janice M. Kerr, MD
University of Colorado Health Science Center

Joanna Klubo-Gwiezdzinska, MD, PhD, MHSc
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases

Helen M. Lawler, MD
University of Colorado, Denver

Kevin O. Lillehei, MD
University of Colorado Anschutz Medical Campus

Daria Lizneva, MD, PhD
Icahn School of Medicine at Mount Sinai

Naim Maalouf, MD
University of Texas Southwestern Medical Center

Susan J. Mandel, MD, MPH
Perelman School of Medicine
University of Pennsylvania

Michael Mannstadt, MD
Massachusetts General Hospital
Harvard Medical School

Sarah E. Mayson, MD
University of Colorado School of Medicine

Shlomo Melmed, MD
Cedars-Sinai Medical Center

Deborah P. Merke, MD, MS
National Institutes of Health

Mark E. Molitch, MD
Northwestern University
Feinberg Medical School

Lynnette K. Nieman, MD
National Institutes of Health

Asha Pathak, MD
Cedars-Sinai Medical Center

Anne Peters, MD
University of Southern California

Daniel A. Pryma, MD
University of Pennsylvania Perelman School of Medicine

Melissa S. Putman, MD
Boston Children's Hospital

Stephen M. Rosenthal, MD
University California, San Francisco

Micol S. Rothman, MD
University of Colorado, Denver

Joshua D. Safer, MD
Mount Sinai Health System
Icahn School of Medicine at Mount Sinai

Marzieh Salehi, MD, MS
University of Texas Health at San Antonio

Desmond Schatz, MD
University of Florida College of Medicine

Dolores M. Shoback, MD
University of California, San Francisco
VA Medical Center

Jennifer A. Sipos, MD
The Ohio State University

Julie A. Sosa, MD, MA
University of California, San Francisco

Robert C. Stanton, MD
Joslin Diabetes Center
Beth Israel Deaconess Medical Center
Harvard Medical School

Paul M. Stewart, MD
University of Leeds, United Kingdom

Cynthia A. Stuenkel, MD
University of California, San Diego

Dennis M. Styne, MD
University of California, Davis

Tamara J. Vokes, MD
University of Chicago

Steven G. Waguespack, MD
University of Texas MD Anderson Cancer Center

Nelson B. Watts, MD
Mercy Health

Kelly L. Wentworth, MD
University of California, San Francisco

Margaret E. Wierman, MD
University of Colorado School of Medicine

Michael W. Yeh, MD
University of California, Los Angeles

William F. Young, Jr., MD, MSc
Mayo Clinic

Philip S. Zeitler, MD, PhD
Children's Hospital Colorado
University of Colorado

ANNUAL MEETING STEERING COMMITTEE CLINICAL CHAIRS

Gregory A. Brent, MD, ENDO 2019 Chair
VA Greater LA Healthcare

Susan A. Sherman, MD, Physician-In-Practice Chair
Aurora Medical Associates, PC

Ghada El-Hajj Fuleihan, MD, MPH, Clinical Science Chair
American University of Beirut

Annual Meeting Steering Committee Clinical Peer Reviewers
Eliot Brinton, MD; Francesco S. Celi, MD; Mark S. Cooper, MD,PHD, FRCP, FRACP; Ann Danoff, MD; Dawn B. Davis, MD,PhD; Marie B. Demay, MD; Matthew T. Drake, MD, PhD; Maralyn R. Druce, MD, PhD; Richard A. Feelders, MD,PhD; Lauren M. Fishbein, MD, PhD; Larry A. Fox, MD; Megan R. Haymart, MD; Anders Juul, MD,PhD,DMSC; Bassil Kublaoui, MD; Margareta D. Pisarska, MD; Peter Kopp, MD; Nicola Napoli, MD, PhD; Sally Radovick, MD; Jennifer A. Sipos, MD; Adrian V. Vella, MD, FRCP; Selma F. Witchel, MD

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s Annual Meeting Steering Committee.  

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationship(s) as of January 1, 2019: Bradley D. Anawalt, MD, Other; Self; Up to Date Author. Wiebke Arlt, MD, DSc, Consulting Fee; Self; Diurnal, Spruce Bioscience, Consultant. Research Investigator; Self; Diurnal, Research Investigator (PI) for clinical studies. Richard J. Auchus, MD, PhD, Consulting Fee; Self; US Anti-Doping Agency. Ricardo Azziz, MD, MPH, MBA, Consulting Fee; Self; Medtronic Minimed, Fractyl Laboratories, Up to Date, Ansh labs, Latitude Capital. Grant Recipient; Self; Ferring Pharmaceuticals. Stock Owner; Self; Global (Martin) PET Imaging. Andrew J. Bauer, MD, Advisory Board Member; Self; IBSA Pharma Inc. Carolyn B. Becker, MD, Other; Self; Up to Date. Sarah L. Berga, MD, Advisory Board Member; Self; AMAG. Research Investigator; Self; Ferring Pharmaceuticals. Other; Self; Salem Academy and College, Up to Date. Daniel H. Bessesen, MD, Other; Self; Enteromedics. Petter M. Bjornstad, MD, Speaker; Self; Horizon Pharma. Other; Self; Boehringer Ingelheim. Marcelle I. Cedars, MD, Research Funding; Self; Ferring Pharmaceuticals. Marc-Andre Cornier, MD, Grant Recipient; Self; Regeneron Pharmaceuticals. Wouter W. de Herder, MD, PhD, Advisory Board Member; Self; Novartis Pharmaceuticals, Ipsen. Grant Recipient; Self; Ipsen. Peter R. Ebeling, MD, Advisory Board Member; Self; Amgen Inc, Alexion Pharmaceuticals, Inc. Grant Recipient; Self; Amgen Inc, Eli Lilly & Company, Novartis Pharmaceuticals, Alexion Pharmaceuticals, Inc. Speaker; Self; Amgen Inc, Eli Lilly & Company. Robert Eckel, MD, Advisory Board Member; Self; Sanofi-Aventis, Regeneron Pharmaceuticals, Merck, Novo Nordisk. Azeez Farooki, MD, Consultant; Self; Amgen. Sergio Fazio, MD, PhD, Consulting Fee; Self; Kowa, Akcea Therapeutics, Amgen Inc, Aegerion Pharmaceuticals. Kenneth Feingold, MD, Advisory Board Member; Self; Regeneron Pharmaceuticals, Amarin. Speaker; Self; Merck & Co., Regeneron Pharmaceuticals, Sanofi. Andrea Giustina, MD, Consulting Fee; Self; Ipsen, Novartis Pharmaceuticals, Pfizer, Inc. Jens O Jorgensen, MD, PhD, Advisory Board Member; Self; Pfizer, Inc., Novo Nordisk, Ipsen. Grant Recipient; Self; Merck, Novartis Pharmaceuticals. Research Investigator; Self; Pfizer, Inc.. Speaker; Self; Novartis Pharmaceuticals, Ipsen, Pfizer, Inc., Sandoz. Laurence Katznelson, MD, Advisory Board Member; Self; Pfizer, Inc. Research Investigator; Self; Novartis Pharmaceuticals. Helen M. Lawler, MD, Consulting Fee; Self; Decision Resources Group Consulting. Research Investigator; Self; XOMA, Eiger BioPharmaceuticals, Xeris Pharmaceuticals,Inc. Michael Mannstadt, MD, Advisory Board Member; Self; Shire. Consulting Fee; Self; Ascendis. Employee; Spouse; Radius Health, Inc. Sarah E. Mayson, MD, Research Investigator; Self; Rosetta Genomics, CBLPath. Mark E. Molitch, MD, Advisory Board Member; Self; Sanofi. Consulting Fee; Self; Merck, Pfizer, Inc.. Grant Recipient; Self; Bayer, Inc., Novartis Pharmaceuticals, Jansen Pharmaceuticals. Lynnette K. Nieman, MD, Research Investigator; Self; HRA Pharmaceuticals. Anne Peters, MD, Advisory Board Member; Self; Abbott Laboratories, Eli Lilly & Company, Lexicon Pharmaceuticals, Inc., Mannkind Corporation, Merck, Novo Nordisk, Sanofi. Grant Recipient; Self; AstraZeneca, Mannkind Corporation, Dexcom. Speaker; Self; Novo Nordisk. Daniel A. Pryma, MD, Advisory Board Member; Self; 511 Pharma. Consulting Fee; Self; Progenics, Actinium Pharmaceuticals, Nordic nanovector. Research Investigator; Self; Siemens, Progenics, 511 Pharma. Stephen M. Rosenthal, MD, Advisory Board Member; Self; Endo Pharmaceuticals. Joshua D. Safer, MD, Advisory Board Member; Self; Endo Pharmaceuticals. Employee; Spouse; Parexel. Julie A. Sosa, MD, MA, Other; Self; Member, Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry supported by GlaxoSmithKline, Novo Nordisk, Astra Zeneca, Eli Lilly. Robert C. Stanton, MD, Advisory Board Member; Self; Jansen Pharmaceuticals, Global Renal Advisory Board. Tamara J. Vokes, MD, Advisory Board Member; Self; Radius Health, Inc, Shire. Consulting Fee; Self; Radius Health, Inc, Shire. Research Investigator; Self; Radius Health, Inc, Shire. Speaker; Self; Radius Health, Inc, Shire. Nelson B. Watts, MD, Advisory Board Member; Self; Amgen Inc, Amgen. Consulting Fee; Self; Abbvie, Sanofi. Speaker; Self; Amgen Inc, Radius Health, Inc. Philip S. Zeitler, MD, PhD, Consulting Fee; Self; Merck, Novo Nordisk, Boehringer Ingelheim, Janssen Research & Development Company.

The following faculty reported no relevant financial relationships as of January 1, 2019: Jasna Aleksova, MBBS, BMedSci; Katherine Araque, MD; Linda A. Barbour, MSPH, MD; Henry B. Burch, MD; Herbert Chen, MD; Ellen L. Connor, MD; Laura E. Dichtel, MD; William T. Donahoo, MD; Andrea Dunaif, MD; Patricia Y. Fechner, MD; James W. Findling, MD; Maria Fleseriu, MD; Stephen Franks, MBBS, MD; Sheila M. Fraser, MBChB, MD; Jacqueline N. Gutmann, MD; Bryan Haugen, MD; Camilo Jimenez, MD; Jacqueline Jonklaas, MD, PhD; Janice M. Kerr, MD; Joanna Klubo-Gwiezdzinska, MD, PhD, MHSc; Kevin O. Lillehei, MD; Daria Lizneva, MD, PhD; Naim Maalouf, MD; Susan J. Mandel, MD, MPH; Asha Pathak, MD; Melissa S. Putman, MD; Micol S. Rothman, MD; Marzieh Salehi, MD, MS; Desmond Schatz, MD; Dolores M. Shoback, MD; Jennifer A. Sipos, MD; Paul M. Stewart, MD; Cynthia A. Stuenkel, MD; Dennis M. Styne, MD; Steven G. Waguespack, MD; Kelly L. Wentworth, MD; Margaret E. Wierman, MD; Michael W. Yeh, MD; William F. Young, Jr., MD, MSc.

The following AMSC peer reviewers reported relevant financial relationship(s) as of January 1, 2019: Eliot Brinton, MD, Advisor and Speaker: Akcea, Amarin, Amgen, Kowa, Merck, Regeneron, Sanofi-Aventis and an Advisor, Balchem, PTS Diagnostics; Speaker, Boehringer-Ingelheim, Novo Nordisk. Francesco S. Celi, MD, MHSc, Advisory Board Member, LioTriDev, IBSA. Dawn B. Davis, MD, PhD, Site PI for clinical trial, Eiger Pharmaceuticals. Marie B. Demay, MD, (Spouse) CMO - Syros Pharmaceuticals. Maralyn R. Druce, MD, PhD, Advisory Board Member – Specific Consultations, Ipsen. Richard A. Feelders, MD, PhD, Research Grant Recipient, Novartis, Ipsen. Anders Juul, MD, PhD, DMSC, Speakers Bureau, Novo Nordisk, Pfizer, Ferring, Merck, Bayer, Sponsor and PI of a clinical multicenter trial (NESGAS), Department research grant, Ferring, Department funding to participate in the clinical trial (PORIYA), Co-investigator in a Ferring-sponsored clinical trial, Department grantee, Diurnal, and Principal investigator for participation in a multicenter study (RCT) on long-acting hydrocortisone (Chronocort) in CAH. Nicola Napoli, MD, PhD, European Advisory Board Member, UCB, Eli Lilly, Consultant, Amgen, Lilly. Sally Radovick, MD, Consultant regarding GH Treatment, CVS Caremark; retail pharmacy and health care company. Jennifer A. Sipos, MD, Advisory Board Consultant and Speaker, Genzyme. Adrian V. Vella, MD, FRCP, Principal Investigator, Novo Nordisk, Investigator, XOMA (multi-center study), Member of Advisory Board, VTV Therapeutics, Bristol Myers Squibb.

The following AMSC peer reviewers reported no relevant financial relationships as of January 1, 2019: Gregory A. Brent, MD; Mark S. Cooper, MD, PhD; Ann Danoff, MD; Matthew T. Drake, MD, PhD; Ghada El-Hajj Fuleihan, MD, MPH; Lauren M. Fishbein, MD, PhD; Larry A. Fox, MD; Megan R. Haymart, MD; Peter Kopp, MD; Bassil Kublaoui, MD, PhD; Margareta D. Pisarska, MD; Susan A. Sherman, MD; Selma F. Witchel, MD.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMERS
The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

USE OF PROFESSIONAL JUDGMENT:
The educational content in this enduring activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.  

DRUGS AND DOSAGES:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE
The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.  

PRIVACY AND CONFIDENTIALITY STATEMENT
The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.  

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This activity is not supported by educational grant(s) or other funds from any commercial supporter. 

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.The Endocrine Society designates this activity for a maximum of 30.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

METHOD OF PARTICIPATION
This enduring material is presented in print format. The estimated time to complete this activity, including review of material, is 30 hours. Participants must achieve a minimum score of 70% to claim CME credit. After initially completing the module, if participants do not achieve a minimum score of 70%, they have the option to change their answers and make additional attempts to achieve a passing score. Participants also have the option to clear all answers and start over.

AMA PRA CATEGORY 1 CREDIT (CME) INFORMATION
To receive a maximum of 30.0 AMA PRA Category 1 Credits™, participants must complete the online interactive module and activity evaluation located at https://education.endocrine.org/MTP2019. Participants must achieve a minimum score of 70% to claim CME credit. After initially completing the module, if participants do not achieve a minimum score of 70%, they have the option to change their answers and make additional attempts to achieve a passing score. Learners also have the option to clear all answers and start over.  

LAST REVIEW DATE: February 2019

ACTIVITY RELEASE DATE: March 17, 2019

ACTIVITY EXPIRATION DATE:
March 30, 2021 (date after which this enduring material is no longer certified for AMA PRA Category 1 Credits™)
For questions about content or obtaining CME credit, please contact the Endocrine Society at http://education.endocrine.org/contact.

Available Credit

  • 30.00 AMA PRA Category 1 Credits
  • 30.00 CME Certificate of Participation

Accreditation Period

Course opens: 
03/11/2019
Course expires: 
03/31/2021

You must first purchase this through our online store. Once you have completed your purchase you will receive access to this CME activity.

Visit the Online Store to purchase today.